Skip to content

Microbicides pose new challenges for design of research studies

Microbicides 2004 marks new wave of HIV prevention trials

ARV-based HIV microbicides advanced by ground-breaking partnership

Rectal HIV microbicides still a distant prospect

Fosamprenavir recommended for approval as Telzir in Europe

Atazanavir interactions with tenofovir and Viagra included on new US labelling

Tipranavir emergency use programme expands

Tenofovir/FTC once daily tablet ready by 2005

Atazanavir, once daily protease inhibitor, now available in UK